In a 17‑year‑old female with treatment‑resistant dissociative seizures, intellectual disability, and a history of depressive episodes, which metabolic disorders are associated with both seizures and depression?

Metabolic Conditions Associated with Dissociative Seizures and Depression

In a 17-year-old female with treatment-resistant dissociative seizures, intellectual disability, and depression, you should pursue metabolic workup focusing on organic acidemias, urea cycle disorders, mitochondrial disorders, and disorders of creatine metabolism—all of which can present with seizures, intellectual disability, and psychiatric manifestations including depression.

Key Metabolic Disorders to Consider

Organic Acidemias and Amino Acid Disorders

Several organic acidemias present with the triad of seizures, intellectual disability, and psychiatric symptoms:

• Phenylketonuria (PKU) can present with psychiatric symptoms including anxiety, depression, and phobias when metabolic control is relaxed, alongside intellectual disability and seizures 1
• Glutaric acidemia type I presents with neurologic abnormalities including seizures and intellectual disability 1
• Maple syrup urine disease manifests with seizures, developmental delay, and intellectual disability 1
• Tyrosinemia type I can cause neurologic abnormalities including seizures 1

Urea Cycle Disorders

Hyperammonemia from urea cycle defects presents with neuropsychiatric manifestations:

• Ornithine transcarbamylase (OTC) deficiency and other urea cycle disorders cause psychiatric manifestations including irritability, learning disabilities, delusion, and psychosis, along with seizures and neurodevelopmental delay 1
• Late-onset hyperammonemia typically presents with failure to thrive, psychiatric symptoms, and neurological manifestations including seizures 1

Disorders of Creatine Metabolism

• X-linked creatine transporter defect (SCL6A8 gene) presents with neurobehavioral changes in the autism spectrum, hypotonia, seizures, and intellectual disability 1
• Disorders of creatine transport or metabolism are specifically associated with seizures and psychiatric phenotypes 1

GABA Metabolism Disorders

• Succinic semialdehyde dehydrogenase deficiency presents with seizures and psychiatric symptoms 1
• Disorders of γ-aminobutyric acid metabolism are associated with seizures and neuropsychiatric manifestations 1

Mitochondrial Disorders

Mitochondrial dysfunction presents with:

• Constitutional symptoms, hypotonia, repeated regressions, seizures, and psychiatric manifestations 1
• Multiple organ dysfunctions alongside neuropsychiatric symptoms 1

Clinical Indicators Warranting Metabolic Testing

The American College of Medical Genetics guidelines specify these red flags 1:

• Seizures (particularly treatment-resistant)
• Intellectual disability or developmental delay
• Lethargy or poor physical endurance
• Hypotonia/dystonia
• Developmental regression (especially associated with illness or fever)
• Metabolic acidosis or acid/base disturbances
• Failure to thrive or poor growth
• Multisystem involvement (cardiac, hepatic, or renal)
• Cyclic vomiting
• Lactic acidosis

Recommended Metabolic Workup

Based on ACMG guidelines, the following first-tier evaluation is appropriate 1:

1. Complete blood count (to assess for anemia with elevated mean corpuscular volume)
2. Serum metabolic profile (electrolytes, glucose, liver function, renal function)
3. Serum amino acids
4. Urine organic acids analysis 1
5. Urine screening for glycosaminoglycans
6. Ammonia level (if any suggestion of hyperammonemia)
7. Lactate and pyruvate (if mitochondrial disorder suspected)
8. Creatine metabolism studies (urine creatine/creatinine ratio, guanidinoacetate)

Important Clinical Caveats

Dissociative vs. Epileptic Seizures

While this patient has dissociative seizures, it's critical to recognize that metabolic disorders can present with both epileptic and non-epileptic manifestations 1. Key features distinguishing functional/dissociative seizures include sustained eye closure (90.2% sensitivity), pelvic thrusting, and prolonged duration (median 180 seconds) 2.

Depression-Epilepsy Bidirectional Relationship

Depression and seizures have a bidirectional relationship through shared neurobiological mechanisms 3, 4:

• Hyperactive hypothalamic-pituitary-adrenal axis
• Structural/functional limbic abnormalities
• Altered glutamatergic, GABAergic, and serotonergic activity
• Immunological disturbances

This means metabolic disorders affecting these pathways can manifest with both seizures and depression 3, 4.

Psychiatric Comorbidity in Intellectual Disability

Psychiatric disorders occur at least three times more often in children with intellectual disability, with particularly high rates of anxiety and depressive disorders 1. This makes the combination of intellectual disability, seizures, and depression a particularly strong indicator for metabolic investigation.

Treatment Resistance as a Red Flag

A lifetime history of depressive disorders is associated with poor response of seizure disorders to pharmacotherapy 3, 4. In this patient with treatment-resistant dissociative seizures and depression, underlying metabolic pathology could be contributing to both conditions and their refractoriness to standard treatment.

Why This Matters for Morbidity and Mortality

Early identification of treatable metabolic disorders is critical because:

• Many metabolic disorders are treatable (e.g., PKU with dietary restriction, urea cycle disorders with nitrogen scavengers, creatine deficiency with supplementation) 1
• Untreated metabolic disorders lead to progressive neurodegeneration, worsening intellectual disability, and increased seizure burden 1
• Some metabolic crises (e.g., hyperammonemic coma) are life-threatening and require urgent intervention 1
• The psychiatric manifestations (depression, anxiety) may improve with metabolic treatment rather than requiring separate psychiatric medication 1